IDEAL: Artificial Intelligence and Big Data for Early Lung Cancer Diagnosis Study (IDEAL)
IDEAL: Artificial Intelligence and Big Data for Early Lung Cancer Diagnosis Prospective Study (Phase 2)
Sponsor: Optellum Ltd.
A observational or N/A phase clinical study on Lung Cancer and Pulmonary Nodule, Multiple, this trial is completed. The trial is conducted by Optellum Ltd. and has accumulated 7 data snapshots since 2018. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.
Status Flow
Change History
7 versions recorded-
Sep 2024 — Present [monthly]
Completed
-
Jul 2024 — Sep 2024 [monthly]
Completed
-
Sep 2022 — Jul 2024 [monthly]
Completed
Status: Recruiting → Completed
-
May 2021 — Sep 2022 [monthly]
Recruiting
Status: Unknown Status → Recruiting
-
Jan 2021 — May 2021 [monthly]
Unknown Status
▶ Show 2 earlier versions
-
Dec 2020 — Jan 2021 [monthly]
Unknown Status
Status: Recruiting → Unknown Status
-
Dec 2018 — Dec 2020 [monthly]
Recruiting
First recorded
Aug 2018
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Optellum Ltd.
- University of Oxford
For direct contact, visit the study record on ClinicalTrials.gov .